Movement Disorder: 帕金森患者,脑白质病变和病情进展密切相关

2022-01-14 Freeman MedSci原创

在PD中,WMHs和认知恶化之间存在关联

在最常见的白质(WM)宏观结构改变中,白质高信号(WMHs)在T2加权磁共振成像(MRI)扫描中很容易识别。WMHs与年龄增长和正常老化的认知能力下降有关。在帕金森病(PD)中,先前横断面研究的证据表明,WMH总体积与认知和/或运动障碍之间存在关联。以前的一项纵向MRI研究显示,帕金森病患者的运动或认知能力下降与WMH体积增加之间没有关联。

WM微结构的改变也与PD的神经变性有关。使用弥散张量(DT)MRI的横断面研究显示,弥散的WM微结构损伤与PD患者的运动和认知障碍程度有关。只有少数研究调查了弥散张量MRI改变的纵向演变,显示弥散各向异性(FA)的减少和平均弥散率(MD)的增加,反映了PD的严重性。

然而,这些研究评估的是全脑WM,并没有考虑影响DT MRI指标的WMHs的位置和严重程度。只有少数报告专门评估了PD中正常外观白质(NAWM)的参与情况,他们没有发现PD患者与健康对照组相比有明显的改变,也没有发现与临床特征有任何关联。


藉此,意大利IRCCS San Raffaele Scientific Institute的Pietro Giuseppe Scamarcia等人,系统地探究了WMHs和NAWM DT MRI改变的演变,以及它们与大群PD患者运动和认知障碍进展的关系,并进行长达4年的纵向跟踪。

共有154名帕金森病患者每年接受一次临床、认知和磁共振成像(MRI)评估,为期4年。60名健康对照组在基线时接受了同样的方案。确定了WMH,并测量了WMH的总体积。WMH也被用作排除掩码来定义正常外观的白质(NAWM)。使用基于TBSS,获得全脑WM和NAWM的弥散张量(DT)MRI指标。线性混合效应模型定义了变量之间的纵向演变和关联。使用线性回归和Cox比例危害模型测试了WM改变作为疾病进展的风险因素。

他们发现:在基线时,与对照组相比,PD患者的所有DT MRI指标都出现了改变。

纵向来看,DT MRI指标没有明显变化,也没有发现与临床变量的关联。WMH体积随时间变化,并与整体认知、执行功能和语言的损害有关。基线WMH体积是进展为轻度认知障碍的一个中等风险因素。

该研究的重要意义在于发现了:在PD中,WMHs和认知恶化之间存在关联,而WM微结构损伤对临床恶化的贡献可忽略不计。通过MRI评估的WMHs可以为监测PD患者认知障碍的发展提供一个重要工具。



原文出处:
Scamarcia PG, Agosta F, Spinelli EG, et al. Longitudinal White Matter Damage Evolution in Parkinson’s Disease. Mov Disord. Published online November 22, 2021:mds.28864. doi:10.1002/mds.28864

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-02-03 cmsvly
  4. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

相关资讯

JNNP:帕金森病奖励处理中断及其与多巴胺状态和神经精神综合征的关系-系统评价和荟萃分析

帕金森病 (PD) 是全球增长最快的神经系统疾病 ,估计每年的社会成本与痴呆症相当。 传统上被概念化为运动障碍,非运动症状,包括情绪、认知和动机的中断,很常见,而且比运动症状对健康相关生活质量的负面影

JAMA Neurology: COMT抑制剂对帕金森左旋多巴疗法辅助效果不佳

与MAO-B抑制剂或多巴胺激动剂作为左旋多巴治疗不可控PD患者的辅助治疗相比,COMT抑制剂的患者分级生活质量更差。

Mov Disord:DTI研究发现丘脑背内侧核游离水与帕金森病认知能力下降相关

丘脑背内侧核 FW是一种有希望的早期帕金森病认知进展的生物标志物,有助于临床试验中识别认知保护疗法。FW是这些结果的可靠评估模式。

Front.aging-neurosci-FGF21调节小胶质细胞极化,减弱帕金森病小鼠和细胞模型的神经变性

帕金森病 (PD) 是一种与年龄相关的神经退行性疾病,其特征是中脑多巴胺能神经元的慢性变性。PD 过程的确切机制尚不清楚,迫切需要新的早期检测标志物和治疗靶点

Neurology:帕金森病患者前额叶皮质血氧水平依赖性(BOLD)变异性反映环境适应应变性和习得稳定性有限

近日,研究人员通过比较普通行走和双任务行走评估任务难度对HBO2变异性的影响,将增加的HBO2变异性与对环境挑战的灵活适应、降低的HBO2变异性与性能的稳定性联系起来。结果表明,两个概念在PD作用有限

帕金森病进展期运动症状管理和非运动症状管理

2021年9月17日至22日,国际帕金森病与运动障碍(MDS)学术大会以线上会议形式举行,带来了帕金森病(PD)进展期运动症状管理和非运动症状管理。

拓展阅读

Nature Medicine:重塑帕金森病治疗前景:Prasinezumab在早期帕金森病快速进展亚型中的疗效分析

文章探讨了Prasinezumab这种单克隆抗体在早期帕金森病中的潜在的治疗作用。

【帕金森病专题分享】探索帕金森病进展及诊疗全攻略

帕金森病日来临之际,我们特别推出了帕金森病专题系列文章。无论你是初入此领域的新手,还是经验丰富的专家,这里都有你需要的知识和信息。点击立即阅读,共同提升帕金森病诊疗水平!

话题:帕金森病的真相你了解多少?

我们欢迎各位老师,学者们在下方评论区共同探讨帕金森病的各个方面,包括但不限于:帕金森病的介绍、早期症状、体征、预防等都可一起分享出来。

European Radiology:弥散基础频谱成像检测早期帕金森病黑质和白质束的病理改变

为了解决弥散张量成像的局限性,研究发展了弥散基谱成像 (DBSI)以粗量化各向异性扩散张量反映轴突的完整性,其在多种中枢神经系统疾病中的敏感性和准确性已被证实。

帕金森病睡眠量表修订版(PDSS-2)

帕金森病睡眠量表修订版(PDSS-2)

神经科一周速递:热点解读进展大盘点!

一周热点分享 ,紧跟神经科学前沿,让每一次诊疗都更精准,点击立即查看!

2024 NICE 诊断指南:帕金森病远程监测设备 [DG51]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-25

2023 NICE 技术鉴定指南:左旋多巴/卡比多巴组合治疗伴有运动症状的晚期帕金森病[TA934]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-11-29

帕金森病患者睡眠障碍评估与护理干预的最佳证据总结

浙江中医药大学护理学院 · 2023-08-10

早中期帕金森病患者运动管理的最佳证据总结

山东第一医科大学附属省立医院老年神经内科 · 2023-05-10